Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans Frontières.
We describe the short-term results of highly active antiretroviral therapy (HAART) in seven projects in low and middle income countries. A total of 743 adults were included, and clinical, immunological and virological responses were analysed. At 6 months, outcomes were similar to those observed in western countries, and the probability of remaining on treatment was 94%. The challenge now is to extend access to HAART to the millions in urgent need.
Tassie
Jean-Michel
JM
Epicentre, Paris, France.
Szumilin
Elisabeth
E
Calmy
Alexandra
A
Goemaere
Eric
E
D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003906:Developing Countries; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010349:Patient Compliance / Q000706:statistics & numerical data; D016896:Treatment Outcome
D019380:Anti-HIV Agents